Equities

Bastide le Confort Medical SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Bastide le Confort Medical SA

Actions
  • Price (EUR)24.80
  • Today's Change1.70 / 7.36%
  • Shares traded156.00
  • 1 Year change--
  • Beta0.5801
Data delayed at least 20 minutes, as of Feb 13 2026 14:11 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Bastide le Confort Medical SA is a France-based company specializes in home health services for the elderly, ill, and handicapped. The Company activity is organized around three families of products and services such as home care equipment and services, respiratory assistance equipment and services, perfusion and nutrition equipment and services, It provides hospital beds, personal assistance products, etc. The Company provides mainly respirators, oxygen concentrators, and oxygen tanks; The offers perfusion, nutrition, and insulin pumps and syringe-drivers. It offers devices to support diabetic patients towards daily comfort and a normal life. The Company offers wide range of products and services to relieve patients losing their autonomy. It fer tailor-made, solutions for a secure, humane, and deeply respectful care pathway.

  • Revenue in EUR (TTM)491.18m
  • Net income in EUR3.02m
  • Incorporated1976
  • Employees3.69k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.